A na-ejikarị INR atụ mmetụta nke ọgwụ mgbochi afọ ime n'ọrịa thromboembolic. A na-ahụ INR ogologo oge na ọgwụ mgbochi afọ ime, DIC, enweghị vitamin K, hyperfibrinolysis na ihe ndị ọzọ. A na-ahụkarị INR mkpụmkpụ n'ọnọdụ hypercoagulable na nsogbu thrombotic. INR, nke a makwaara dị ka International Normalized Ratio, bụ otu n'ime ihe nnwale ọrụ coagulation. INR dabere na PT reagent iji dozie International Sensitivity Index ma gbakọọ nsonaazụ ya site na usoro ndị metụtara ya. Ọ bụrụ na INR dị oke elu, enwere ihe ize ndụ nke ọbara ọgbụgba a na-achịkwaghị achịkwa. INR nwere ike inyocha ma jiri mmetụta nke ọgwụ mgbochi afọ ime nke ọma. N'ozuzu, a na-eji ọgwụ mgbochi afọ ime warfarin, a kwesịkwara inyocha INR oge niile. Ị kwesịrị ịma na ọ bụrụ na ejiri warfarin, a ga-enyocha INR mgbe niile. Ndị ọrịa nwere thrombosis venous ga-aṅụ warfarin n'ọnụ, a ga-edebekwa uru INR n'ozuzu na 2.0-2.5. Maka ndị ọrịa nwere atrial fibrillation, a na-anọgide na-enwe uru inr nke warfarin ọnụ n'etiti 2.0-3.0. Ọnụọgụ INR karịrị 4.0 nwere ike ibute ọbara ọgbụgba a na-achịkwaghị achịkwa, ebe ọnụọgụ INR dị n'okpuru 2.0 anaghị enye ọgwụ mgbochi coagulation dị irè.

Aro: ka na-aga ụlọ ọgwụ nkịtị maka nyocha, ma na-agbaso ndokwa dọkịta ọkachamara.